/BELL.L

BELL.L Stock - Belluscura plc

Q: What is the analyst price target for BELL.L?

Analyst price target information is not currently available for BELL.L.

Q: What is BELL.L's market cap?

Market capitalization information is not currently available for BELL.L.

Healthcare|Medical - Devices|LSE

$0.75+3.45%

+$0.03 (+3.45%) • Sep 2

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.83

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BELL.L

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.70

52W High$18.00

52W Low$0.49

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$825,409	$1.40M	$420,316	N/A	$128,701
Gross Profit	$-4,203,118	$68,105	$-52,171	N/A	$14,316
Gross Margin	-509.2%	4.9%	-12.4%	N/A	11.1%
Operating Income	$-17,691,721	$-10,396,950	$-5,186,657	$-1,945,189	$-1,185,421
Net Income	$-18,517,619	$-8,762,833	$-5,030,641	$-2,004,680	$-1,544,829
Net Margin	-2243.4%	-626.8%	-1196.9%	N/A	-1200.3%
EPS	$-0.14	$-0.07	$-0.05	$-0.02	$-0.01

Company Overview

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Visit Website

Earnings History & Surprises

BELL.L

Beat Rate

Last 2 quarters

Avg Surprise

-116.9%

EPS vs Estimate

Beats / Misses

0/2

Last 12 quarters

Latest EPS

$-0.03

Q3 2024

EPS Surprise History

Q4 20

No data

Q2 21

No data

Q4 21

No data

Q2 22

No data

Q2 23

No data

Q3 23

No data

Q2 24

-197.4%

$-0.07vs$-0.02

Q3 24

-36.5%

$-0.03vs$-0.02

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2025	Jun 26, 2025	$-0.02	—	—	—
Q3 2024	Sep 26, 2024	$-0.02	$-0.03	-36.5%	✗ MISS
Q2 2024	Jun 27, 2024	$-0.02	$-0.07	-197.4%	✗ MISS
Q3 2023	Sep 13, 2023	—	$-0.04	—	—
Q2 2023	Jun 29, 2023	—	$-0.02	—	—
Q2 2022	Jun 30, 2022	—	$-0.03	—	—
Q4 2021	Dec 31, 2021	—	$-0.02	—	—
Q2 2021	Jun 30, 2021	—	$-0.02	—	—
Q4 2020	Dec 31, 2020	—	$-0.02	—	—
Q2 2020	Jun 30, 2020	—	$0.00	—	—
Q4 2019	Dec 31, 2019	—	$-0.01	—	—
Q2 2019	Jun 30, 2019	—	$-0.01	—	—
Q4 2018	Dec 31, 2018	—	$-0.00	—	—
Q2 2018	Jun 30, 2018	—	$-0.00	—	—
Q4 2017	Dec 31, 2017	—	$-0.02	—	—
Q2 2017	Jun 30, 2017	—	$-0.02	—	—
Q4 2016	Nov 30, 2016	—	$-0.08	—	—
Q2 2016	May 30, 2016	—	$-0.07	—	—